Also trades as: AFP.AX (ASX) · $vol 0M
AFT.NZ NZE
AFT Pharmaceuticals Limited
1W: -0.5%
1M: -0.2%
3M: +17.8%
YTD: +17.5%
1Y: +68.7%
3Y: +23.1%
5Y: -1.6%
NZ$4.30 ($2.41)
-0.07 (-1.60%)
Weekly Expected Move ±2.4%
NZ$4
NZ$4
NZ$4
NZ$4
NZ$5
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Smart Money Score
No convergence signal
Key Statistics
Market CapNZ$458.3M ($256.6M)
52W Range2.79-4.85
Volume9,913
Avg Volume31,603
Beta0.46
DividendNZ$0.03
Analyst Ratings
No analyst coverage
Company Info
CEOHartley Atkinson
Employees126
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
IPO Date2015-12-21
Websiteaftpharm.com
129 Hurstmere Road
Auckland, AU 0622
NZ
Auckland, AU 0622
NZ
64 9 488 0232
About AFT Pharmaceuticals Limited
AFT Pharmaceuticals, along with its subsidiaries, focuses on the creation and distribution of pharmaceutical products across New Zealand, Australia, Asia, and other global markets. Their extensive product range addresses a variety of health categories, including but not limited to allergy relief, cold and flu remedies, digestive health, eye care, first aid essentials, nail and oral care, pain management, skincare solutions, and nutritional supplements. This company was established in 1997 and its main office is located in Auckland, New Zealand.
Latest News
No recent news
Recent Insider Trades
No insider trades found